Abstract
Previous studies have provided anatomical evidence that the functional neuregulin receptor, ErbB4, is present within the ventral midbrain where it is co-localized to dopamine neurons of the substantia nigra and ventral tegmental area. In this study, we provide evidence that neuregulin1-β (a.k.a. heregulin1-β), a neuregulin-1 gene isoform that preferentially binds to and activates the ErbB4 receptor, evokes an almost immediate overflow of striatal dopamine when injected into a region just dorsal to the ipsilateral substantia nigra. These data are indicative that neuregulins can modulate the activity of mesostriatal dopaminergic neurons.
Original language | English |
---|---|
Pages (from-to) | 116-119 |
Number of pages | 4 |
Journal | Brain Research |
Volume | 1028 |
Issue number | 1 |
DOIs | |
State | Published - Nov 26 2004 |
Bibliographical note
Funding Information:This research was supported by DAMD17-01-1-0766 (DOD), DAMD17-02-1-0174 (DOD) and NS39128 (NIH).
Funding
This research was supported by DAMD17-01-1-0766 (DOD), DAMD17-02-1-0174 (DOD) and NS39128 (NIH).
Funders | Funder number |
---|---|
National Institutes of Health (NIH) | |
U.S. Department of Defense | DAMD17-02-1-0174 |
National Institute of Neurological Disorders and Stroke | R01NS039128 |
Keywords
- ErbB4
- Microdialysis
- Nigrostriatal pathway
- Rodent
ASJC Scopus subject areas
- General Neuroscience
- Molecular Biology
- Clinical Neurology
- Developmental Biology